C
Christina S. Kong
Researcher at Stanford University
Publications - 133
Citations - 8098
Christina S. Kong is an academic researcher from Stanford University. The author has contributed to research in topics: Cancer & Head and neck squamous-cell carcinoma. The author has an hindex of 36, co-authored 123 publications receiving 6535 citations. Previous affiliations of Christina S. Kong include University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Lysyl oxidase is essential for hypoxia-induced metastasis
Janine T. Erler,Kevin L. Bennewith,Monica Nicolau,Nadja Dornhöfer,Christina S. Kong,Quynh-Thu Le,Jen-Tsan Ashley Chi,Stefanie S. Jeffrey,Amato J. Giaccia +8 more
TL;DR: It is shown that LOX expression is regulated by hypoxia-inducible factor (HIF) and is associated with Hypoxia in human breast and head and neck tumours, and is a good therapeutic target for preventing and treating metastases.
Journal ArticleDOI
The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society
Geoffrey D. Rubin,Christopher J. Ryerson,Linda B. Haramati,Nicola Sverzellati,Jeffrey P. Kanne,Suhail Raoof,Neil W. Schluger,Annalisa Volpi,Jae-Joon Yim,Ian B.K. Martin,Deverick J. Anderson,Christina S. Kong,Talissa A. Altes,Andrew Bush,Sujal R. Desai,Jonathan G. Goldin,Jin Mo Goo,Marc Humbert,Yoshikazu Inoue,Hans-Ulrich Kauczor,Fengming Luo,Peter J. Mazzone,Mathias Prokop,Martine Remy-Jardin,Luca Richeldi,Cornelia M. Schaefer-Prokop,Noriyuki Tomiyama,Athol U. Wells,Ann N. Leung +28 more
TL;DR: A multidisciplinary panel comprised principally of radiologists and pulmonologists from 10 countries with experience managing COVID-19 patients across a spectrum of healthcare environments evaluated the utility of imaging within three scenarios representing varying risk factors, community conditions, and resource constraints, resulting in five main and three additional recommendations intended to guide medical practitioners in the use of CXR and CT in the management of COIDs.
Journal ArticleDOI
p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma
Christine H. Chung,Qiang Zhang,Christina S. Kong,Jonathan Harris,Elana J. Fertig,Paul M. Harari,Dian Wang,Kevin P. Redmond,George Shenouda,Andy Trotti,David Raben,Maura L. Gillison,Richard C.K. Jordan,Quynh-Thu Le +13 more
TL;DR: Patients with p 16-negative non-OPSCC have worse outcomes than patients with p16-positive non-opsCC, and HPV may also have a role in outcome in a subset of non-OPSC, however, further development of a p16 IHC scoring system in non- OPSCC and improvement of HPV detection methods are warranted.
Journal ArticleDOI
Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer
Jing Shan Lim,Alvaro Ibaseta,Marcus Fischer,Belinda Cancilla,Gilbert O'Young,Sandra Cristea,Vincent C. Luca,Dian Yang,Nadine Jahchan,Cécile Hamard,Martine Antoine,Marie Wislez,Christina S. Kong,Jennifer Cain,Yu-Wang Liu,Ann M. Kapoun,K. Christopher Garcia,Timothy Hoey,Christopher Murriel,Julien Sage +19 more
TL;DR: It is shown that Notch signalling can be both tumour suppressive and pro-tumorigenic in small-cell lung cancer, and the presence of these cells may serve as a biomarker for the use of Notch pathway inhibitors in combination with chemotherapy in select patients with small- cell lung cancer.
Journal ArticleDOI
Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility
Sarah K. Denny,Dian Yang,Chen-Hua Chuang,Jennifer J. Brady,Jing Shan Lim,Barbara M. Grüner,Shin Heng Chiou,Alicia N. Schep,Jessika Baral,Cécile Hamard,Martine Antoine,Marie Wislez,Christina S. Kong,Andrew J. Connolly,Kwon-Sik Park,Julien Sage,William J. Greenleaf,Monte M. Winslow +17 more
TL;DR: The identification of widespread chromatin changes during SCLC progression reveals an unexpected global reprogramming during metastatic progression, and indicates that Nfib is necessary and sufficient to increase chromatin accessibility at a large subset of the intergenic regions.